This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Paion Deutschland Gmbh, Université De Caen Normandie. Active years: 2018.
Company Filing History:
1 out of 1,853 
1 out of 2 
1 out of 23 Years Active: 2018
Title: Fabian Docagne: Innovator in Neurological Treatments
Introduction
Fabian Docagne is a notable inventor based in Paris, France. He has made significant contributions to the field of medical science, particularly in the treatment of neurological and neurodegenerative disorders. His innovative work has the potential to impact many lives.
Latest Patents
Fabian Docagne holds a patent for an antibody that is useful in treating neurological or neurodegenerative disorders. The patent, titled "Antibody useful in neurological or neurodegenerative disorders," describes an anti-NMDA antibody or its fragments and derivatives. This invention is effective in inhibiting the harmful effects of tissue-type plasminogen activator (t-PA) mediated by N-methyl-D-aspartate (NMDA) receptors. It has promising medical applications, especially for conditions like multiple sclerosis. He has 1 patent to his name.
Career Highlights
Throughout his career, Fabian has worked with reputable organizations, including Paion Deutschland GmbH and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Fabian has collaborated with esteemed colleagues such as Richard Macrez and Denis Vivien. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Fabian Docagne is a distinguished inventor whose work in the field of neurological treatments showcases his dedication to improving medical science. His innovative patent has the potential to change the landscape of treatment for neurodegenerative disorders.